ARCHIVES

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

Rauscher To Leave ACS when It Moves To Atlanta; Gadberry To Retire In March; Other VPs Stay On

January 8, 1988

Draft Report Outlines New Toxicological Test Criteria

November 24, 1995

Letter To The Editor: Humor Story On Dands

October 29, 1999

DCCP Board Okays New Projects In Chemoprevention, Other Programs Totaling $5 Million In First Year

December 14, 1979

Pazdur Waxes On Calumet City And Krebiozen; Parkinson Takes Interim CMO Job at Zyngenia

April 27, 2012

HHS, NIH To Help Houston Rebuild Research Facilities.

July 13, 2001